Abstract:Gastric cancer (GC) is a prevalent malignancy, leading to a high incidence of cancer-associated death. Cisplatin (DDP)-based chemotherapy is the principal therapy for clinical GC treatment, but DDP resistance is a severe clinical challenge and the mechanism remains poorly understood. Circular RNAs (circRNAs) have been identified to play crucial roles in modulating the chemoresistance of gastric cancer cells.To explore the effect of circVAPA on chemotherapy resistance during GC progression.The effect of circVAPA on GC progression and chemotherapy resistance was analyzed by MTT assay, colony formation assay, Transwell assay, wound healing assay, and flow cytometry analysis in GC cells and DDP resistant GC cell lines, and tumorigenicity analysis in nude mice . The mechanism was investigated by luciferase reporter assay, quantitative real-time PCR, and Western blot analysis.CircVAPA expression was up-regulated in clinical GC tissues compared with normal samples. CircVAPA depletion inhibited proliferation, migration, and invasion and increased apoptosis of GC cells. The expression of circVAPA, STAT3, and STAT3 downstream genes was elevated in DDP resistant SGC7901/DDP cell lines. CircVAPA knockdown attenuated the DDP resistance of GC cells. Mechanically, circVAPA was able to sponge miR-125b-5p, and miR-125b-5p could target STAT3 in the GC cells. MiR-125b-5p inhibitor reversed circVAPA depletion-enhanced inhibitory effect of DDP on GC cells, and STAT3 knockdown blocked circVAPA overexpression-induced proliferation of DDP-treated SGC7901/DDP cells. The depletion of STAT3 and miR-125b-5p inhibitor reversed circVAPA depletion-induced GC cell apoptosis. Functionally, circVAPA contributed to the tumor growth of SGC7901/DDP cells .CircVAPA promotes chemotherapy resistance and malignant progression in GC by miR-125b-5p/STAT3 signaling. Our findings present novel insights into the mechanism by which circVAPA regulates chemotherapy resistance of GC cells. CircVAPA and miR-125b-5p may be considered as the potential targets for GC therapy.

CircVAPA Exerts Oncogenic Property in Non-Small Cell Lung Cancer by the Mir-876-5p/wnt5a Axis

CircCTNNA1 Acts As a Cerna for Mir-363-3p to Facilitate the Progression of Colorectal Cancer by Promoting CXCL5 Expression

circ0101675 promotes malignant process via sponging miR-1278 and upregulating WNT3A/5A in non-small cell lung cancer

CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma

Circular RNA Circvapa Knockdown Suppresses Colorectal Cancer Cell Growth Process by Regulating Mir-125A/creb5 Axis

Circ_0016760 Serves As a Cancer Promoter in Non-small Cell Lung Cancer Through Mir-876-3p/nova2 Axis

Circular RNA Circβ‐catenin Aggravates the Malignant Phenotype of Non‐small‐cell Lung Cancer Via Encoding a Peptide

CircCAMSAP1 Promotes Non-Small Cell Lung Cancer Proliferation and Inhibits Cell Apoptosis by Sponging Mir-1182 and Regulating BIRC5.

CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis

Circular RNA circ_0101675 Promotes NSCLC Cell Proliferation, Migration, Invasion, Angiogenesis and Immune Evasion by Sponging miR-607/PDL1 Axis

Circular RNA Circvapa Regulates Breast Cancer Cell Migration and Invasion Via Sponging Mir-130A-5p

Circular RNA circVAPA Promotes Cell Proliferation in Hepatocellular Carcinoma

Enhanced expression of circ_0000735 forecasts clinical severity in NSCLC and promotes cell progression via sponging miR-1179 and miR-1182.

Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis

Retracted Article: CircRNA PVT1 Modulates Cell Metastasis Via the Mir-181A-5p/nek7 Axis and Cisplatin Chemoresistance Through Mir-181A-5p-mediated Autophagy in Non-Small Cell Lung Cancer

Circ-ZKSCAN1 Regulates FAM83A Expression and Inactivates MAPK Signaling by Targeting Mir-330-5p to Promote Non-Small Cell Lung Cancer Progression

Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis

Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis

Hsa_circ_0003528 promotes cell malignant transformation and immune escape via increasing oncogene PDL1 through sponging miR‐511‐3p in non‐small cell lung cancer

Circular RNA Circatp9a Promotes Non-Small Cell Lung Cancer Progression by Interacting with HuR and by Promoting Extracellular Vesicles-Mediated Macrophage M2 Polarization.

Circular RNA circZCCHC6 contributes to tumorigenesis by regulating LPCAT1 via miR-433-3p in non-small cell lung cancer